Last Updated: 16 Sep 2024
Executive Summary
MetLife Inc. (MET) is a leading global provider of insurance, annuities, and employee benefit programs. The company has a strong financial position with a market capitalization of $53.36 billion and an EBITDA of $5.24 billion. MetLife's stock price is currently $76.19, which is within its 52-week range of $56.06 to $78.70. The company has a trailing PE ratio of 20.7 and a forward PE ratio of 7.78. Analysts have a consensus rating of "Buy" on MetLife, with a target price of $86.28.
Company Overview
MetLife was founded in 1868 and is headquartered in New York City. The company has operations in over 60 countries and serves 90 million customers. MetLife's core businesses include life insurance, annuities, and employee benefits. The company also offers a range of other financial products and services, such as mutual funds, variable annuities, and trust services.
Fundamental Analysis
MetLife's financial performance has been solid in recent years. The company's revenue has grown at a compound annual growth rate (CAGR) of 3.5% over the past five years. Net income has grown at a CAGR of 4.2% over the same period. MetLife's operating margin is 7.17%, and its return on assets is 0.42%. The company has a strong balance sheet with $242.2 billion in total assets and $160.7 billion in total liabilities.
Technical Analysis
MetLife's stock price has been trending higher in recent months. The stock is currently above its 50-day and 200-day moving averages. The relative strength index (RSI) is 58.5, which indicates that the stock is neither overbought nor oversold.
Short Term Outlook
MetLife's stock price is expected to continue to trend higher in the short term. The company's fundamentals are strong, and the technical analysis indicates that the stock is in a bullish trend. Investors may want to consider buying MetLife stock at current levels.
Long Term Outlook
MetLife's long-term outlook is positive. The company is a leader in the insurance industry and is well-positioned to benefit from the growing demand for insurance products. MetLife's stock price is expected to continue to grow in the long term. Investors may want to consider holding MetLife stock for the long term.
Analyst Recommendations
Analysts have a consensus rating of "Buy" on MetLife, with a target price of $86.28. Four analysts have a rating of "Strong Buy," eight analysts have a rating of "Buy," four analysts have a rating of "Hold," and no analysts have a rating of "Sell" or "Strong Sell."
